Viral suppression function of intracellular antibody against C-terminal domain of rabies virus phosphoprotein

Acta Biochimica et Biophysica Sinica

Volumn 47, Issue 10, 2015, Pages 815-823

  Liu, Yang ^a   Sun, Lina ^a   Yu, Pengcheng ^a   Li, Aqian ^a   Li, Chuan ^a   Tang, Qing ^a   Li, Dexin ^a   Liang, Mifang ^a  

^a Chinese CDC   (China)

Author keywords

human fab library; intracellular antibody (intrabody); rabies virus (RV); rabies virus phosphoprotein (RV P); single chain variable fragment (scFv)

Indexed keywords

PHOSPHOPROTEIN; PROTEIN BINDING; VIRUS ANTIBODY;

BINDING SITE; CHEMISTRY; DRUG EFFECTS; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; RABIES VIRUS; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

ANTIBODIES, VIRAL; BINDING SITES; HEK293 CELLS; HUMANS; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RABIES VIRUS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS REPLICATION;

EID: 84943538231     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmv060     Document Type: Article

References (26)

1. Rupprecht CE, Hanlon CA, Hemachudha T. Rabies re-examined. Lancet Infect Dis 2002, 2: 327-343.
2. Israsena N, Mahavihakanont A, Hemachudha T. Rabies virus infection and microRNAs. Adv Virus Res 2011, 79: 329-344.
3. Kaku Y, Noguchi A, Hotta K, Yamada A, Inoue S. Inhibition of rabies virus propagation in mouse neuroblastoma cells by an intrabody against the viral phosphoprotein. Antiviral Res 2011, 91: 64-71.
4. Smith AJ. New horizons in therapeutic antibody discovery: opportunities and challenges versus small-molecule therapeutics. J Biomol Screen 2015, 20: 437-453.
5. Mitragotri S, Burke PA, Langer R. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov 2014, 13: 655-672.
6. Gerard FC, Ribeiro Ede A Jr, Leyrat C, Ivanov I, Blondel D, Longhi S, Ruigrok RW, et al. Modular organization of rabies virus phosphoprotein. J Mol Biol 2009, 388: 978-996.
7. Nishizono A, Yamada K. [Rhabdoviruses]. Uirusu 2011, 62: 183-196.
8. Le Mercier P, Jacob Y, Tanner K, Tordo N. A novel expression cassette of lyssavirus shows that the distantly related Mokola virus can rescue a defective rabies virus genome. J Virol 2002, 76: 2024-2027.
9. Nadin-Davis SA, Fehlner-Gardiner C, Sheen M, Wandeler AI. Characterization of a panel of anti-phosphoprotein monoclonal antibodies generated against the raccoon strain of rabies virus. Virus Res 2010, 152: 126-136.
10. Chenik M, Chebli K, Blondel D. Translation initiation at alternate in-frame AUG codons in the rabies virus phosphoprotein mRNA is mediated by a ribosomal leaky scanning mechanism. J Virol 1995, 69: 707-712.
11. Gigant B, Iseni F, Gaudin Y, Knossow M, Blondel D. Neither phosphoryl-ation nor the amino-terminal part of rabies virus phosphoprotein is required for its oligomerization. J Gen Virol 2000, 81: 1757-1761.
12. Chenik M, Schnell M, Conzelmann KK, Blondel D. Mapping the interacting domains between the rabies virus polymerase and phosphoprotein. J Virol 1998, 72: 1925-1930.
13. Rieder M, Brzozka K, Pfaller CK, Cox JH, Stitz L, Conzelmann KK. Genetic dissection of interferon-antagonistic functions of rabies virus phosphopro-tein: inhibition of interferon regulatory factor 3 activation is important for pathogenicity. J Virol 2011, 85: 842-852.
14. Bakker AB, Marissen WE, Kramer RA, Rice AB, Weldon WC, Niezgoda M, Hanlon CA, et al. Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants. J Virol 2005, 79: 9062-9068.
15. Koch J, Liang M, Queitsch I, Kraus AA, Bautz EK. Human recombinant neutralizing antibodies against hantaan virus G2 protein. Virology 2003, 308: 64-73.
16. Yu L, Zhang L, Sun L, Lu J, Wu W, Li C, Zhang Q, et al. Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodies. PLoS One 2012, 7: e38291.
17. Sun L, Chen Z, Yu L, Wei J, Li C, Jin J, Shen X, et al. Generation and characterization of neutralizing human recombinant antibodies against antigen-ic site II of rabies virus glycoprotein. Appl Microbiol Biotechnol 2012, 96: 357-366.
18. Kashyap AK, Steel J, Oner AF, Dillon MA, Swale RE, Wall KM, Perry KJ, et al. Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci USA 2008, 105: 5986-5991.
19. Schmitz U, Versmold A, Kaufmann P, Frank HG. Phage display: a molecular tool for the generation of antibodies-a review. Placenta 2000, 21 (Suppl A): S106-S112.
20. Persic L, Roberts A, Wilton J, Cattaneo A, Bradbury A, Hoogenboom HR. An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. Gene 1997, 187: 9-18.
21. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol 1938, 27: 493-497.
22. Mavrakis M, McCarthy AA, Roche S, Blondel D, Ruigrok RW. Structure and function of the C-terminal domain of the polymerase cofactor of rabies virus. J Mol Biol 2004, 343: 819-831.
23. Castel G, Chteoui M, Caignard G, Prehaud C, Mehouas S, Real E, Jallet C, et al. Peptides that mimic the amino-terminal end of the rabies virus phosphoprotein have antiviral activity. J Virol 2009, 83: 10808-10820.
24. Toriumi H, Honda Y, Morimoto K, Tochikura TS, Kawai A. Structural relationship between nucleocapsid-binding activity of the rabies virus phosphoprotein (P) and exposure of epitope 402-13 located at the C terminus. J Gen Virol 2002, 83: 3035-3043.
25. Nadin-Davis SA, Abdel-Malik M, Armstrong J, Wandeler AI. Lyssavirus P gene characterisation provides insights into the phylogeny of the genus and identifies structural similarities and diversity within the encoded phospho-protein. Virology 2002, 298: 286-305.
26. Ribeiro Ede A Jr, Leyrat C, Gerard FC, Albertini AA, Falk C, Ruigrok RW, Jamin M. Binding of rabies virus polymerase cofactor to recombinant circular nucleoprotein-RNA complexes. J Mol Biol 2009, 394: 558-575.